InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: None

Monday, 03/05/2018 9:03:31 AM

Monday, March 05, 2018 9:03:31 AM

Post# of 459505
TGD is at it again.... this time it will mean something... IMO

Christopher U Missling, Director of Anavex Life Sciences Corp. and a director of the company, recently acquired 1,650 shares of the company. The buys took place at $2.41 per share, on March 02, 2018. Missling now owns 1,013,900 shares of the company. Missling operates out of New York, NY. Some additional info was provided as follows:
The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

https://www.sec.gov/Archives/edgar/data/1314052/000161577418001587/0001615774-18-001587-index.htm

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News